451
Views
0
CrossRef citations to date
0
Altmetric
Review

Cancer Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 5 of 5

, PhD, RDN

References

  • Abbott PJ. Comfrey: assessing the low-dose health risk. Med J Aust. 1988;149(11–12):678–682.
  • Abnet CC. Carcinogenic food contaminants. Cancer Invest. 2007;25(3):189–196.
  • Alonso-Amelot ME, Avendaño M. Possible association between gastric cancer and bracken fern in Venezuela: an epidemiologic study. Int J Cancer 2001;91:252–259.
  • Alonso-Amelot ME, Avendaño M. Human carcinogenesis and bracken fern: a review of the evidence. Curr Med Chem. 2002;9(6):675–686.
  • Alscher DM, Klotz U. Drug interaction of herbal tea containing St. John's wort with cyclosporine. Transpl Int. 2003;16(7):543–544.
  • American Institute for Cancer Research. CUP: Continuous Update Project. http://www.aicr.org/continuous-update-project/. Accessed May 2, 2017.
  • Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25(9):2097–2116.
  • Baliga MS, Katiyar SK. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem Photobiol Sci. 2006;5(2):243–253.
  • Behl M, Nyska A, Chhabra RS, Travlos GS, Fomby LM, Sparrow BR, et al. Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to kava kava. Food Chem Toxicol. 2011;49(11):2820–2829.
  • Béliveau R, Gingras D. Role of nutrition in preventing cancer. Can Fam Physician. 2007;53(11):1905–1911.
  • Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol. 2016;7(1):54–86.
  • Blumenthal M, Busse WR, Godberg A, Gruenwald J, Hall T, Riggins W, Rister RS. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, Texas; 1998.
  • Boberg EW, Miller EC, Miller JA, Poland A, Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver. Cancer Res. 1983;43(11):5163–5173.
  • Bode AM, Dong Z. Toxic phytochemicals and their potential risks for human cancer. Cancer Prev Res (Phila). 2015;8(1):1–8.
  • Boh B. Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat Anticancer Drug Discov. 2013;8(3):255–287.
  • Borchert P, Miller JA, Miller EC, Shires TK. 1'-Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse. Cancer Res. 1973;33(3):590–600.
  • Boudreau MD, Beland FA, Nichols JA, Pogribna M. Toxicology and carcinogenesis studies of a nondecolorized [corrected] whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser. 2013;(577):1–266.
  • Boudreau MD, Mellick PW, Olson GR, Felton RP, Thorn BT, Beland FA. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis Miller (aloe vera) in F344/N rats. Toxicol Sci. 2013;131(1):26–39.
  • Brown, AC. An overview of herb and dietary supplement efficacy, safety, and government regulation in the United States with suggested improvements. Part 1 of 5 series. Food Chem Toxicol. 2017a;107(Pt A):449–471.
  • Brown AC. Liver toxicity related to herb and dietary supplements: online table of medical case reports. Part 2 of 5 series. Food Chem Toxicol. 2017b;107(Pt A):472–501.
  • Brown AC. Kidney toxicity related to herb and dietary supplements: online table of medical case reports. Part 3 of 5 series. Food Chem Toxicol 2017c;107(Pt A):502–519.
  • Brown AC. Heart toxicity related to herb and dietary supplements: online table of medical case reports. Part 4 of 5 series. J Diet Supp. 2017 (in press).
  • Brown AC, Onopa J, Holck P, Kaufusi P, Kabasawa D, Craig WJ, et al. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clin Toxicol (Phila). 2007;45(5):549–556.
  • Casari I, Falasca M. Diet and pancreatic cancer prevention. Cancers (Basel). 2015;7(4):2309–2317.
  • Castellsagué X, Muñoz N, De Stefani E, Victora CG, Castelletto R, Rolón PA. Influence of maté drinking, hot beverages and diet on esophageal cancer risk in South America. Int J Cancer. 2000;88(4):658–664.
  • Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005;14:2093–2097.
  • Chan PC, Rider CV, Nyska A, Bishop JB, Chhabra RS, Cora MC, et al. National Toxicology Program. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies). Natl Toxicol Program Tech Rep Ser. 2013;(578):1–183.
  • Chen CH, Dickman KG, Huang CY, Moriya M, Shun CT, Tai HC, et al. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int J Cancer. 2013;133(1):14–20.
  • Chen CH, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci U S A. 2012;109(21):8241–8246.
  • Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013;14(4):2407–2412.
  • Clauson-Kaas F, Jensen PH, Jacobsen OS, Juhler RK, Hansen HC. The naturally occurring carcinogen ptaquiloside is present in groundwater below bracken vegetation. Environ Toxicol Chem. 2014;33(5):1030–1034.
  • Cosyns JP. Aristolochic acid and Chinese herbs nephropathy: a review of the evidence to date. Drug Saf. 2003;26(1):33–48.
  • Cosyns JP, Goebbels RM, Liberton V, Schmeiser HH, Bieler CA, Bernard AM. Chinese herbs nephropathy-associated slimming regimen induces tumours in the fore stomach but no interstitial nephropathy in rats. Arch Toxicol. 1998;72(11):738–743.
  • Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis. 1999;33(6):1011–1017.
  • Dasanayake AP, Silverman AJ, Warnakulasuriya S. Maté drinking and oral and oro-pharyngeal cancer: a systematic review and meta-analysis. Oral Oncol. 2010;46(2):82–86.
  • Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74(2):158–169.
  • Deneo-Pellegrini H, De Stefani E, Boffetta P, Ronco AL, Acosta G, Correa P, et al. Maté consumption and risk of oral cancer: case-control study in Uruguay. Head Neck. 2013;35(8):1091–1095.
  • De Ruyck K, De Boevre M, Huybrechts, De Saeger S. Dietary mycotoxins, co-exposure, and carcinogenesis in humans: short review. Mutat Res Rev Mutat Res. 2015;766:32–41.
  • De Stefani E, Correa P, Fierro L, Fontham E, Chen V, Zavala D. Black tobacco, maté, and bladder cancer. A case-control study from Uruguay. Cancer. 1991;67(2):536–540.
  • De Stefani E, Deneo-Pellegrini H, Ronco AL, Boffetta P, Correa P, Mendilaharsu M, et al. Diet patterns and risk of squamous cell oesophageal carcinoma: a case-control study in Uruguay. Asian Pac J Cancer Prev. 2014;15(6):2765–2769.
  • De Stefani E, Fierro L, Mendilaharsu M, Ronco A, Larrinaga MT, Balbi JC, et al. Meat intake, ‘maté’ drinking and renal cell cancer in Uruguay: a case-control study. Br J Cancer. 1998;78(9):1239–1243.
  • De Stefani E, Boffetta P, Deneo-Pellegrini H, Correa P, Ronco AL, Brennan P, et al. Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer. 2007;7:57.
  • Dufay S, Worsley A, Monteillier A, Avanzi C, Sy J, Ng TF, et al. Herbal tea extracts inhibit Cytochrome P450 3A4 in vitro. J Pharm Pharmacol. 2014;66(10):1478–1490.
  • Dunnick JK, Nyska A. The toxicity and pathology of selected dietary herbal medicines. Toxicol Pathol. 2013;41(2):374–386.
  • Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med. 2002;252(2):107–113.
  • Evans IA, Jones RS, Mainwaring-Burton R. Passage of bracken fern toxicity into milk. Nature 1972;237:107–108.
  • Evans IA, Widdop B, Jones RS, Barber GD, Leach H, Jones DL, et al. The possible human hazard of the naturally occurring bracken carcinogen. Biochem J. 1971;124(2):29P–30P.
  • Fang X, Wei J, He X, An P, Wang H, Jiang L, Shao D, Liang H, Li Y, Wang F, Min J. Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015;51(18):2820–2832.
  • FDA. Aristolochic acid: letter to industry associations regarding safety concerns related to the use of botanical products containing aristolochic acid. http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm096374.htm. Published April 9, 2001a. Accessed May 2, 2017.
  • FDA. Aristolochic acid: listing of botanical ingredients of concern. http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm095283.htm. Published April 9, 2001b. Accessed May 1, 2017.
  • FDA. FDA advises dietary supplement manufacturers to remove comfrey products from the market. http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm111219.htm. Published July 6, 2001c. Accessed May 2, 2017.
  • FDA. Poisonous plant database. https://www.accessdata.fda.gov/scripts/plantox/textResults.cfm. Updated May 2008. Accessed May 2, 2017.
  • FDA. Safety. Kava (Piper methysticum). https://wayback.archive-it.org/7993/20170112171412/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154577.htm. Updated August 20, 2013. Accessed May 2, 2017.
  • FDA. Code of Federal Regulations. Title 21, Volume 3. PART 189—Substances Prohibited from Use in Human Food. Subpart C—Substances Generally Prohibited from Direct Addition or Use as Human Food. Sec. 189.180 Safrole. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=189.180. Updated September 21, 2016. Accessed May 2, 2017. Foote J, Cohen B. Medicinal herb use and the renal patient. J Ren Nutr 1998;8(1):40–42.
  • Fox DW, Hart MC, Bergeson PS, Jarrett PB, Stillman AE, Huxtable RJ. Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J Pediatr. 1978;93(6):980–982.
  • Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, et al. Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study. Int J Cancer. 2008;122:2330–2336.
  • Galpin OP, Whitaker CJ, Whitaker R, Kassab JY. Gastric cancer in Gwynedd. Possible links with bracken. Br J Cancer. 1990;61:737–740.
  • Ghadirian P. Thermal irritation and esophageal cancer in northern Iran. Cancer. 1987;60(8):1909–1914.
  • Ghadirian P, Vobecky J, Vobecky JS. Factors associated with cancer of the oesophagus: an overview. Cancer Detect Prev. 1988;11(3–6):225–234.
  • Goldenberg D. Maté: a risk factor for oral and oropharyngeal cancer. Oral Oncol. 2002;38(7):646–649.
  • Goldenberg D, Golz A, Joachims HZ. The beverage maté: a risk factor for cancer of the head and neck. Head Neck. 2003;25(7):595–601.
  • Grollman AP. Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ Mol Mutagen. 2013;54(1):1–7.
  • Gruenwald J, Brendler T, Jaenicke C (Eds). PDR for herbal medicines. Montvale, NJ: Thomson Healthcare, 2007.
  • Guh JY, Chen HC, Tsai JF, Chuang LY. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis. 2007;49(5):626–633.
  • Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006;7(1):79–88.
  • Haines JD Jr. Sassafras tea and diaphoresis. Postgrad Med. 1991;90(4):75–76.
  • Haller C, Kearney T, Bent S, Ko R, Benowitz N, Olson K. Dietary supplement adverse events: report of a one-source poison center surveillance project. J Med Toxicol. 2008;4(2):84–92.
  • Harris PN, Chen KK. Development of hepatic tumors in rats following ingestion of Senecio longilobus. Cancer Res. 1970;30(12):2881–2886.
  • Helferich WG, Andrade JE, Hoagland MS. Phytoestrogens and breast cancer: a complex story. Inflammopharmacology. 2008;16(5):219–226.
  • Hirono I, Mori H, Culvenor CC. Carcinogenic activity of coltsfoot, Tussilago farfara l. 1976;67(1):125–129.
  • Hirono I, Mori H, Haga M. Carcinogenic activity of Symphytum officinale. J Natl Cancer Inst. 1978;61(3):865–869.
  • Hirono I, Shimizu M, Fushimi K, Mori H, Kato K. Carcinogenic activity of Petasites japonicus Maxim., a kind of coltsfoot. 1973;64(5):527–528.
  • Hoenerhoff MJ, Pandiri AR, Snyder SA, Hong HH, Ton TV, Peddada S, et al. Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two sources differ from spontaneous liver tumors in cancer gene mutations and genomic pathways. Toxicol Pathol. 2013;41(6):826–841.
  • Hsieh SC, Lai JN, Chen PC, Chen CC, Chen HJ, Wang JD. Is Duhuo Jisheng Tang containing Xixin safe? A four-week safety study. Chin Med. 2010;5(1):6.
  • IARC. Bracken fern. IARC Monographs. 1987;Supp7:135–136. http://monographs.iarc.fr/ENG/Monographs/suppl7/Suppl7-34.pdf.
  • IARC. Maté. IARC Monographs. 1991;51:273–287. http://monographs.iarc.fr/ENG/Monographs/vol51/mono51-9.pdf.
  • IARC. Aristolochia species and aristolochic acids. IARC Monographs. 2002a;82:69–128. http://monographs.iarc.fr/ENG/Monographs/vol82/mono82-6B.pdf.
  • IARC. C. Rubia tinctorum, morida officinalis and anthraquinones. IARC Monographs. 2002b;82:129–151. http://monographs.iarc.fr/ENG/Monographs/vol82/index.php.
  • IARC. Senecio species and riddelliine. IARC Monographs. 2002c;82:153–168. http://monographs.iarc.fr/ENG/Monographs/vol82/mono82-6D.pdf.
  • IARC. Plants containing aristolochic acid. IARC Monographs. 2012;100A:347–362. http://monographs.iarc.fr/ENG/Monographs/vol100A/mono100A-23.pdf.
  • IARC. Some drugs and herbal products. IARC Monographs. 2016;108. http://monographs.iarc.fr/ENG/Monographs/vol108/index.php.
  • IARC. List of IARC monographs. http://monographs.iarc.fr/ENG/Publications/List-of-Volumes.pdf. Accessed May 2, 2017.
  • Inoue K, Yoshida M, Takahashi M, Fujimoto H, Shibutani M, Hirose M, et al. Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium-term multi-organ bioassay. Cancer Sci. 2009;100(12):2261–2267.
  • Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk—a systematic review. Int J Cancer. 2009;125(3):491–524.
  • Ju YH, Doerge DR, Helferich WG. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice. Food Chem Toxicol. 2008;46(1):310–320.
  • Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M. Paclitaxel and its evolving role in the management of ovarian cancer. Biomed Res Int. 2015;2015:413076.
  • Kanaan N, Hassoun Z, Raggi C, Jadoul M, Mourad M, De Meyer M, Aydin S, et al. Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy. Transplantation. 2016;100(2):416–21.
  • Kinjo J, Nakano D, Fujioka T, Okabe H. Screening of promising chemotherapeutic candidates from plants extracts. J Nat Med. 2016;70(3):335–360.
  • Kooti W, Servatyari K, Behzadifar M, Asadi-Samani M, Sadeghi F, Nouri B, Zare Marzouni H. Effective medicinal plant in cancer treatment, Part 2 [published online ahead of print January 1, 2017]. J Evid Based Complement Altern Med. doi:10.1177/2156587217696927.
  • Kwan LP, Mok MM, Ma MK, Lam MF. Acute drug toxicity related to drinking herbal tea in a kidney transplant recipient. Ren Fail. 2014;36(2):309–312.
  • Lai MN, Lai JN, Chen PC, Hsieh SC, Hu FC, Wang JD. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. Am J Kidney Dis. 2010;55(3):507–518.
  • Lemy A, Wissing KM, Rorive S, Zlotta A, Roumeguere T, Muniz Martinez MC, et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-source follow-up. Am J Kidney Dis. 2008;51(3):471–477.
  • Li XZ, Ramzan I. Role of ethanol in kava hepatotoxicity. Phytother Res. 2010;24(4):475–480.
  • Lipsky MM, Hinton DE, Klaunig JE, Trump BF. Biology of hepatocellular neoplasia in the mouse. I. Histogenesis of safrole-induced hepatocellular carcinoma. J Natl Cancer Inst. 1981;67(2):365–376.
  • Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr. 2013;4(3):384S–92S.
  • Loria D, Barrios E, Zanetti R. Cancer and yerba maté consumption: a review of possible associations. Rev Panam Salud Publica. 2009;25(6):530–539.
  • Magee PJ, Rowland I. Soy products in the management of breast cancer. Curr Opin Clin Nutr Metab Care. 2012;15(6):586–591.
  • Manteiga R, Park DL, Ali SS. Risks associated with consumption of herbal teas. Rev Environ Contam Toxicol. 1997;150:1–30.
  • Marcus DM, Grollman AP. Botanical medicines—the need for new regulations. N Engl J Med. 2002;347(25):2073–2076.
  • Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst. 2002;94(16):1247–1249.
  • Mei N, Guo L, Fu PP, Heflich RH, Chen T. Mutagenicity of comfrey (Symphytum officinale) in rat liver. Br J Cancer. 2005;92(5):873–875.
  • Mei N, Guo L, Zhang L, Shi L, Sun YA, Fung C, et al. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006;11(7):742–752.
  • Muñoz N, Victora CG, Crespi M, Saul C, Braga NM, Correa P. Hot maté drinking and precancerous lesions of the oesophagus: an endoscopic survey in southern Brazil. Int J Cancer. 1987;39(6):708–709.
  • National Toxicology Program. Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis canadensis) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser. 2010;(562):1–188.
  • National Toxicology Program. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser. 2012;(571):1–186.
  • Neergheen-Bhujun VS. Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int. 2013;2013:804086.
  • Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 sources from 1981 to 2010. J Nat Prod. 2012;75(3):311–335.
  • Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342(23):1686–1692.
  • Nortier JL, Vanherweghem JL. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) Toxicology. 2002;181–182:577–580.
  • Nowack R, Nowak B. Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrol Dial Transplant. 2005;20(11):2554–2556.
  • Ortiz Cansado A, Crespo Valadés E, Morales Blanco P, Sáenz de Santamaría J, González Campillejo JM, Ruiz Téllez T. [Veno-occlusive liver disease due to intake of Senecio vulgaris tea]. Gastroenterol Hepatol. 1995;18(8):413–416.
  • Palmer S. Diet, nutrition, and cancer. Prog Food Nutr Sci. 1985;9(3–4):283–341.
  • Pandey S, Shaw PN, Hewavitharana AK. Review of procedures used for the extraction of anti-cancer compounds from tropical plants. Anticancer Agents Med Chem. 2015;15(3):314–326.
  • Pandiri AR, Sills RC, Hoenerhoff MJ, Peddada SD, Ton TV, Hong HH, et al. Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors. Toxicol Pathol. 2011;39(7):1065–1074.
  • Perla V, Jayanty SS. Biguanide related compounds in traditional antidiabetic functional foods. Food Chem. 2013;138(2–3):1574–1580.
  • Pintos J, Franco EL, Oliveira BV, Kowalski LP, Curado MP, Dewar R. Maté, coffee, and tea consumption and risk of cancers of the upper aerodigestive tract in southern Brazil. Epidemiology. 1994;5(6):583–590.
  • Rates SM. Plants as source of drugs. Toxicon. 2001;39(5):603–613.
  • Reuber MD. Neoplasms of the forestomach in mice ingesting dihydrosafrole. Digestion. 1979;19(1):42–47.
  • Ruschitzka F, Meier PJ, Turina M, Lüscher TF, Noll G. Acute heart transplant rejection due to Saint John's wort. Lancet. 2000;355(9203):548–549.
  • Russo M, Russo GL, Daglia M, Kasi PD, Ravi S, Nabavi SF, et al. Understanding genistein in cancer: the “good” and the “bad” effects: a review. Food Chem. 2016;196:589–600.
  • Schiff PL Jr, Srinivasan VS, Giancaspro GI, Roll DB, Salguero J, Sharaf MH. The development of USP botanical dietary supplement monographs, 1995–2005. J Nat Prod. 2006;69(3):464–472.
  • Seawright AA. Directly toxic effects of plant chemicals which may occur in human and animal foods. Nat Toxins 1995;3:227–32; discussion 42.
  • Sewram V, De Stefani E, Brennan P, Boffetta P. Maté consumption and the risk of squamous cell esophageal cancer in Uruguay. Cancer Epidemiol Biomarkers Prev. 2003;12(6):508–513.
  • Spagnuolo C, Russo GL, Orhan IE, Habtemariam S, Daglia M, Sureda A, et al. Genistein and cancer: current status, challenges, and future directions. Adv Nutr. 2015;6(4):408–419.
  • Stefani ED, Moore M, Aune D, Deneo-Pellegrini H, Ronco AL, Boffetta P, et al. Maté consumption and risk of cancer: a multi-site case-control study in Uruguay. Asian Pac J Cancer Prev. 2011;12(4):1089–1093.
  • Stefanovic V, Toncheva D, Polenakovic M. Balkan nephropathy. Clin Nephrol. 2015;83(7 Suppl 1):64–69.
  • Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005;43(5):901–910.
  • Stillman AE, Huxtable RJ, Fox D, Hart M, Bergeson P. Pyrrolizidine (Senecio) poisoning in Arizona: severe liver damage due to herbal teas. Ariz Med. 1977;34(8):545–546.
  • Sweet ES, Standish LJ, Goff BA, Andersen MR. Adverse events associated with complementary and alternative medicine use in ovarian cancer patients. Integr Cancer Ther. 2013;12(6):508–516.
  • Toth B. Carcinogenic fungal hydrazines. In Vivo. 1991;5(2):95–100.
  • Triolet J, Shaik AA, Gallaher DD, O'Sullivan MG, Xing C. Reduction in colon cancer risk by consumption of kava or kava fractions in carcinogen-treated rats. Nutr Cancer. 2012;64(6):838–846.
  • Turati F, Rossi M, Pelucchi C, Levi F, La Vecchia C. Fruit and vegetables and cancer risk: a review of southern European studies. Br J Nutr. 2015;113(Suppl 2):S102–S110.
  • Vaclavik L, Krynitsky AJ, Rader JI. Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography-multistage fragmentation mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(5):784–791.
  • van Duijnhoven FJ, Bueno-De-Mesquita HB, Ferrari P, Jenab M, Boshuizen HC, Ros MM, et al. Fruit, vegetables, and colorectal cancer risk: the European prospective investigation into cancer and nutrition. Am J Clin Nutr. 2009;89:1441–1452.
  • Vanherweghem JL. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium. J Altern Complement Med 1998;4(1):15–16.
  • Vanherweghem JL, Tielemans C, Simon J, Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Nephrol Dial Transplant. 1995;10(2):270–273.
  • Vassallo A, Correa P, De Stéfani E, Cendán M, Zavala D, Chen V, et al. Esophageal cancer in Uruguay: a case-control study. J Natl Cancer Inst. 1985;75(6):1005–1009.
  • Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26(4):665–673.
  • Vesselinovitch SD, Rao KV, Mihailovich N. Transplacental and lactational carcinogenesis by safrole. Cancer Res. 1979;39(11):4378–4380.
  • Vilar JH, García M, Cabrera P. [Veno-occlusive liver disease induced by Senecio vulgaris toxicity]. Gastroenterol Hepatol. 2000;23(6):285–286.
  • Westendorf J, Pfau W, Schulte A. Carcinogenicity and DNA adduct formation observed in ACI rats after long-term treatment with madder root, Rubia tinctorum L. Carcinogenesis. 1998;19(12):2163–2168.
  • Wiedenfeld H. Plants containing pyrrolizidine alkaloids: toxicity and problems. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011;28(3):282–292.
  • Wu F, Groopman JD, Pestka JJ. Public health impacts of foodborne mycotoxins. Annu Rev Food Sci Technol. 2014;5:351–372.
  • Xu T, Beelman RB, Lambert JD. The cancer preventive effects of edible mushrooms. Anticancer Agents Med Chem. 2012;12(10):1255–1263.
  • Yamani A, Bunel V, Antoine MH, Husson C, Stévigny C, Duez P, et al. Substitution between Aristolochia and Bryonia genus in North-Eastern Morocco: toxicological implications. J Ethnopharmacol. 2015;166:250–260.
  • Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000;35(2):313–318.
  • Yang HY, Chen PC, Wang JD. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference. Biomed Res Int. 2014;2014:569325.
  • Yokohira M, Yamakawa K, Hosokawa K, Matsuda Y, Kuno T, Saoo K, et al. Promotion potential of madder color in a medium-term multi-organ carcinogenesis bioassay model in F344 rats. J Food Sci. 2008;73(3):T26–T32.
  • Yuie-Zhong S. Recent natural products based drug development: a pharmaceutical industry perspective. J Nat Prod. 1998;61:1053–1071.
  • Zhou J, Ouedraogo M, Qu F, Duez P. Potential genotoxicity of traditional Chinese medicinal plants and phytochemicals: an overview. Phytother Res. 2013;27(12):1745–1755.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.